(VIANEWS) - TravelCenters of America LLC (TA), Horizon Therapeutics (HZNP), Boston Scientific (BSX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. TravelCenters of America LLC (TA)
42.1% sales growth and 5.73% return on equity
TravelCenters of America Inc. operates travel centers and standalone restaurants in the United States and Canada.
TravelCenters of America LLC's sales growth this year is expected to be 49.9% and 11.2% for next year.
Year-on-year quarterly revenue growth grew by 52.8%, now sitting on 6.59B for the twelve trailing months.
Volume
Today's last reported volume for TravelCenters of America LLC is 205874 which is 52.32% above its average volume of 135156.
TravelCenters of America LLC's sales growth for the next quarter is 42.1%. The company's growth estimates for the current quarter and the next is 162.1% and 102.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.73%.
Volatility
TravelCenters of America LLC's last day, last week, and last month's current intraday variation average was 3.57%, 1.49%, and 1.85%, respectively.
TravelCenters of America LLC's highest amplitude of average volatility was 4.92% (day), 4.16% (last week), and 4.80% (last month), respectively.
TravelCenters of America LLC's Stock Yearly Top and Bottom Value
TravelCenters of America LLC's stock is valued at $45.04 at 15:22 EST, way below its 52-week high of $64.58 and way higher than its 52-week low of $22.00.
TravelCenters of America LLC's Moving Average
TravelCenters of America LLC's value is way below its 50-day moving average of $52.83 and way above its 200-day moving average of $40.35.2. Horizon Therapeutics (HZNP)
27.5% sales growth and 16.1% return on equity
Horizon Therapeutics Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing of medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally.
Horizon Therapeutics's sales growth this year is anticipated to be 41.2% and 23.5% for next year.
Year-on-year quarterly revenue growth grew by 79.9%, now sitting on 2.56B for the twelve trailing months.
Volume
Today's last reported volume for Horizon Therapeutics is 1185870 which is 25.21% below its average volume of 1585640.
Horizon Therapeutics's sales growth for the next quarter is 27.5%. The company's growth estimates for the present quarter and the next is a negative 11.5% and 10.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.1%.
Volatility
Horizon Therapeutics's last day, last week, and last month's current intraday variation average was 4.57%, 1.27%, and 1.81%, respectively.
Horizon Therapeutics's highest amplitude of average volatility was 5.46% (day), 4.35% (last week), and 4.45% (last month), respectively.
Horizon Therapeutics's Stock Yearly Top and Bottom Value
Horizon Therapeutics's stock is valued at $91.75 at 15:22 EST, way below its 52-week high of $120.54 and way above its 52-week low of $66.41.
Horizon Therapeutics's Moving Average
Horizon Therapeutics's worth is way under its 50-day moving average of $109.80 and below its 200-day moving average of $100.05.3. Boston Scientific (BSX)
17.5% sales growth and 3.69% return on equity
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Boston Scientific's sales growth this year is anticipated to be 21.2% and 7.9% for next year.
Year-on-year quarterly revenue growth grew by 53.6%, now sitting on 11.2B for the twelve trailing months.
Volume
Today's last reported volume for Boston Scientific is 8520080 which is 2.45% below its average volume of 8734320.
Boston Scientific's sales growth is a negative 0% for the current quarter and 17.5% for the next. The company's growth estimates for the ongoing quarter and the next is 8.1% and 91.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.69%.
Volatility
Boston Scientific's last day, last week, and last month's current intraday variation average was 1.15%, 0.78%, and 1.08%, respectively.
Boston Scientific's highest amplitude of average volatility was 4.07% (day), 3.36% (last week), and 2.61% (last month), respectively.
Boston Scientific's Stock Yearly Top and Bottom Value
Boston Scientific's stock is valued at $42.74 at 15:22 EST, below its 52-week high of $46.29 and way above its 52-week low of $32.99.
Boston Scientific's Moving Average
Boston Scientific's value is below its 50-day moving average of $43.43 and below its 200-day moving average of $43.52.Previous days news about Boston Scientific(BSX)
- According to Bloomberg Quint on Thursday, 27 January, "The technology council's board includes representatives of Bain Capital, Putnam Investments, McKinsey & Co., Boston Scientific Corp. and DraftKings Inc."
4. Cerner Corporation (CERN)
6.9% sales growth and 17.48% return on equity
Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally.
Cerner Corporation's sales growth this year is anticipated to be 5.2% and 5.2% for next year.
Year-on-year quarterly revenue growth grew by 9.5%, now sitting on 5.61B for the twelve trailing months.
Volume
Today's last reported volume for Cerner Corporation is 4237690 which is 17.5% below its average volume of 5137190.
Cerner Corporation's sales growth for the next quarter is 6.9%. The company's growth estimates for the ongoing quarter and the next is 12.5% and 12.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.48%.
Volatility
Cerner Corporation's last day, last week, and last month's current intraday variation average was 0.01%, 0.19%, and 0.13%, respectively.
Cerner Corporation's highest amplitude of average volatility was 0.26% (day), 0.61% (last week), and 0.51% (last month), respectively.
Cerner Corporation's Stock Yearly Top and Bottom Value
Cerner Corporation's stock is valued at $91.22 at 15:22 EST, above its 52-week high of $84.20.